EMA Reviews Alcohol Dependency Drug After French Concerns
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced it…
Guideline Outlines How to Taper Benzodiazepines Safely
Long-term, regular use of benzodiazepines is common and can lead to physical dependence and withdrawal when the dose…
Judge could advance Purdue Pharma’s $7B opioid settlement after all 50 states back it
All 50 U.S. states have agreed to the OxyContin maker Purdue Pharma ’s latest plan to settle thousands…
Chatbot Helps Users Adopt a Low FODMAP Diet
SAN DIEGO — Low fermentable oligo-, di-, and monosaccharides and polyols (FODMAPs) dietary advice has been shown to…
Clinicians Push FDA on NarxCare
This article is the second in a series on prescription drug monitoring programs and analysis tools designed to…
Ubrogepant Eases Prodromal Migraine Symptoms
The clinical utility of the calcitonin gene–related peptide (CGRP) receptor antagonist ubrogepant may extend beyond the treatment of…
Animal sedative medetomidine is showing up in the US illegal drug supply, CDC says
NEW YORK (AP) — The animal sedative medetomidine is increasingly showing up in the U.S. illegal drug supply,…
Is This Opioid Algorithm Misleading Doctors, Hurting Patients?
This article is the first in a series on prescription drug monitoring programs and analysis tools designed to…
5 years after Britain left the EU, impact of Brexit is still emerging
LONDON (AP) — Five years ago Friday, two crowds of people gathered near Britain’s Parliament — some with…
What Else Can GLP-1 Drugs Do for Your Patients?
Glucagon-like peptide 1 (GLP-1) receptor agonists are transforming the treatment landscape for type 2 diabetes ( T2D) and…